Breaking News Instant updates and real-time market news.

2021-01-25 18:06:03 EZGO EZGO Technologies $0.00 / + (+0.00%) 18:06 01/25/21 01/25 18:06 01/25/21 18:06	EZGO Technologies 2.8M share IPO priced at $4.00

TODAY'S FREE FLY STORIES

Recommendations	Mondi price target raised to 2,100 GBp at Citi » 14:42 03/04/21 03/04 14:42 03/04/21 14:42 MONDY Mondi $0.00 / + (+0.00%) Citi analyst Deepak Kumar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MONDY Mondi $0.00 / + (+0.00%) 02/26/21 Morgan Stanley Mondi price target raised to 2,100 GBp from 2,050 GBp at Morgan Stanley 02/08/21 BofA Mondi upgraded to Buy from Neutral at BofA 01/25/21 Morgan Stanley Mondi price target raised to 2,050 GBp from 1,900 GBp at Morgan Stanley 01/25/21 JPMorgan Mondi price target raised to 1,740 GBp from 1,570 GBp at JPMorgan
Recommendations	Rio Tinto price target lowered to 5,090 GBp from 5,140 GBp at Morgan Stanley » 14:41 03/04/21 03/04 14:41 03/04/21 14:41 RIO Rio Tinto $82.04 / -1.64 (-1.96%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options RIO Rio Tinto $82.04 / -1.64 (-1.96%) 08:14 Today Turquoise Hill 'committed to ensuring that negotiations with Rio Tinto continue' 03/02/21 Rio Tinto chairman Thompson to not seek re-election as board director 03/02/21 Rio Tinto to dispute ATO amended assessments of $279.8M tax, $36.7M interest 02/26/21 Rio Tinto has awarded over $385M in contracts for Greater Tom Price Operations RIO Rio Tinto $82.04 / -1.64 (-1.96%) 02/18/21 UBS Rio Tinto price target raised to 5,800 GBp from 5,500 GBp at UBS 02/09/21 JPMorgan Rio Tinto price target raised to 7,120 GBp from 6,940 GBp at JPMorgan 02/08/21 JPMorgan Rio Tinto price target lowered to 6,940 GBp from 7,000 GBp at JPMorgan 02/05/21 Fly Intel: Top five analyst initiations RIO Rio Tinto $82.04 / -1.64 (-1.96%) 02/18/21 Rio Tinto willing to enter new agreement with Mongolia, Reuters says 11/25/20 Mongolia seeks review on Rio Tinto's Oyu Tolgoi mine, FT reports 10/15/20 Newmont CEO not interested in Rio Tinto chief job, FT reports RIO Rio Tinto $82.04 / -1.64 (-1.96%) 12/24/20 Unusual call flow in option market yesterday 12/23/20 One year call upside position opened in Rio Tinto
Recommendations	Cairn Energy price target lowered to 235 GBp from 250 GBp at Morgan Stanley » 14:40 03/04/21 03/04 14:40 03/04/21 14:40 CRNCY Cairn Energy $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CRNCY Cairn Energy $0.00 / + (+0.00%) 01/21/21 JPMorgan Cairn Energy price target raised to 226 GBp from 210 GBp at JPMorgan 01/20/21 Peel Hunt Cairn Energy upgraded to Add from Hold at Peel Hunt 01/12/21 Morgan Stanley Cairn Energy price target raised to 250 GBp from 248 GBp at Morgan Stanley 01/11/21 RBC Capital Cairn Energy price target raised to 300 GBp from 150 GBp at RBC Capital
Recommendations	Avast price target lowered to 595 GBp from 610 GBp at Morgan Stanley » 14:40 03/04/21 03/04 14:40 03/04/21 14:40 AVASF Avast $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AVASF Avast $0.00 / + (+0.00%) 01/12/21 Berenberg Avast initiated with a Buy at Berenberg 01/11/21 UBS Avast price target raised to 645 GBp from 600 GBp at UBS 12/10/20 Morgan Stanley Avast price target lowered to 610 GBp from 650 GBp at Morgan Stanley 11/17/20 Citi Avast upgraded to Buy from Neutral at Citi
Recommendations	Taylor Wimpey price target raised to 195 GBp from 180 GBp at Morgan Stanley » 14:39 03/04/21 03/04 14:39 03/04/21 14:39 TWODF Taylor Wimpey $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TWODF Taylor Wimpey $0.00 / + (+0.00%) 03/03/21 Credit Suisse Taylor Wimpey price target raised to 212 GBp from 205 GBp at Credit Suisse 02/08/21 Jefferies Taylor Wimpey upgraded to Buy from Hold at Jefferies 02/03/21 Barclays Taylor Wimpey upgraded to Overweight from Equal Weight at Barclays 01/29/21 Berenberg Taylor Wimpey price target raised to 180 GBp from 130 GBp at Berenberg

Recommendations	Swiss Life price target raised to CHF 446 from CHF 424 at Morgan Stanley » 14:39 03/04/21 03/04 14:39 03/04/21 14:39 SZLMY Swiss Life $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SZLMY Swiss Life $0.00 / + (+0.00%) 14:34 Today Berenberg Swiss Life price target lowered to CHF 492.90 from CHF 501.80 at Berenberg 06:30 Today HSBC Swiss Life downgraded to Hold from Buy at HSBC 03/03/21 JPMorgan Swiss Life price target raised to CHF 460 from CHF 440 at JPMorgan 03/03/21 Credit Suisse Swiss Life price target raised to CHF 455 from CHF 365 at Credit Suisse
Recommendations	Persimmon price target raised to 3,000 GBp from 2,950 GBp at Morgan Stanley » 14:38 03/04/21 03/04 14:38 03/04/21 14:38 PSMMY Persimmon $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PSMMY Persimmon $0.00 / + (+0.00%) 13:24 Today JPMorgan Persimmon price target raised to 3,360 GBp from 3,210 GBp at JPMorgan 02/03/21 Barclays Persimmon upgraded to Overweight from Equal Weight at Barclays 02/01/21 Deutsche Bank Persimmon price target raised to 3,283 GBp from 3,173 GBp at Deutsche Bank 01/29/21 Berenberg Persimmon price target raised to 3,180 GBp from 2,720 GBp at Berenberg
Recommendations	Flutter price target raised to 17,700 GBp from 17,400 GBp at Morgan Stanley » 14:38 03/04/21 03/04 14:38 03/04/21 14:38 PDYPY Flutter Entertainment $0.00 / + (+0.00%) Morgan Stanley analyst Ed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly PDYPY Flutter Entertainment $0.00 / + (+0.00%) 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/23/21 Texas proposes constitutional amendment to legalize sports wagering 02/19/21 NCAA to allow up to 25% capacity at men's basketball tournament PDYPY Flutter Entertainment $0.00 / + (+0.00%) 13:23 Today JPMorgan Flutter price target raised to 15,038 GBp from 14,790 GBp at JPMorgan 03/03/21 RBC Capital Flutter price target raised to 15,700 GBp from 15,000 GBp at RBC Capital 02/26/21 JPMorgan Flutter price target raised to 14,790 GBp from 11,200 GBp at JPMorgan 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds PDYPY Flutter Entertainment $0.00 / + (+0.00%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/28/21 FanDuel, Genius Sports to collaborate on marketing initiative, IGB reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says PDYPY Flutter Entertainment $0.00 / + (+0.00%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test
Recommendations	Elkem ASA price target raised to NOK 30 from NOK 26 at Morgan Stanley » 14:37 03/04/21 03/04 14:37 03/04/21 14:37 ELKEF Elkem ASA $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ELKEF Elkem ASA $0.00 / + (+0.00%) 02/03/21 Nordea Elkem ASA upgraded to Buy from Hold at Nordea 01/27/21 Morgan Stanley Elkem ASA price target raised to NOK 26 from NOK 24 at Morgan Stanley 01/20/21 DNB Markets Elkem ASA downgraded to Hold from Buy at DNB Markets 06/24/20 Citi Elkem ASA downgraded to Sell from Neutral at Citi
Recommendations	Eiffage price target raised to EUR 124 from EUR 121 at Morgan Stanley » 14:37 03/04/21 03/04 14:37 03/04/21 14:37 EFGSY Eiffage $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EFGSY Eiffage $0.00 / + (+0.00%) 03/03/21 RBC Capital Eiffage price target raised to EUR 105 from EUR 100 at RBC Capital 02/25/21 Barclays Eiffage price target raised to EUR 102 from EUR 100 at Barclays 01/14/21 JPMorgan Eiffage price target raised to EUR 92 from EUR 90 at JPMorgan 12/17/20 Morgan Stanley Eiffage price target raised to EUR 117 from EUR 110 at Morgan Stanley

Recommendations	Andritz price target raised to EUR 40 from EUR 38 at Morgan Stanley » 14:36 03/04/21 03/04 14:36 03/04/21 14:36 ADRZY Andritz $0.00 / + (+0.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ADRZY Andritz $0.00 / + (+0.00%) 02/11/21 Deutsche Bank Andritz price target raised to EUR 46 from EUR 38 at Deutsche Bank 11/06/20 JPMorgan Andritz price target raised to EUR 42 from EUR 40 at JPMorgan 11/06/20 Morgan Stanley Andritz price target raised to EUR 38 from EUR 36 at Morgan Stanley 11/06/20 Deutsche Bank Andritz price target raised to EUR 38 from EUR 36 at Deutsche Bank
General news	Wall Street turned sharply lower following Fed Chair Powell » 14:35 03/04/21 03/04 14:35 03/04/21 14:35 Wall Street turned… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Amgen deal for Five Prime 'a nice tuck-in,' says Piper Sandler » 14:34 03/04/21 03/04 14:34 03/04/21 14:34 AMGN Amgen $222.71 / -1.1 (-0.49%) , FPRX Five Prime $37.81 / +16.59 (+78.18%) After Amgen (AMGN)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash 03/02/21 Amgen announces publication with data from Phase 3 study of BLINCYTO FPRX Five Prime $37.81 / +16.59 (+78.18%) 09:00 Today Five Prime trading resumes 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 14:13 Today Goldman Sachs Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs 03/01/21 Piper Sandler Piper Sandler remains buyer of Amgen following asthma data 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley 02/03/21 Credit Suisse Amgen price target lowered to $265 from $280 at Credit Suisse FPRX Five Prime $37.81 / +16.59 (+78.18%) 14:13 Today Goldman Sachs Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs 10:58 Today Wedbush Five Prime downgraded to Neutral from Outperform at Wedbush 10:29 Today Wells Fargo Five Prime downgraded to Equal Weight from Overweight at Wells Fargo 11/16/20 JPMorgan Zai Lab price target raised to $111 from $101 at JPMorgan AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 08:34 Today Amgen backs FY21 adjusted EPS view $16.00-$17.00, consensus $16.85 02/02/21 Amgen sees FY21 adjusted EPS $16.00-$17.00, consensus $17.02 02/02/21 Amgen reports Q4 adjusted EPS $3.81, consensus $3.39 02/02/21 Notable companies reporting after market close FPRX Five Prime $37.81 / +16.59 (+78.18%) 11/03/20 Five Prime reports Q3 EPS (74c), consensus (60c) 13 Nov AMGN AMGN Amgen $222.71 / -1.1 (-0.49%) 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports 01/28/21 Amgen's sotorasib shrank tumors in 37% of trial patients, STAT reports AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 02/08/21 Fly Insider: Harley-Davidson, Amgen among week's notable insider trades 02/03/21 Fly Intel: Wall Street's top stories for Wednesday FPRX Five Prime $37.81 / +16.59 (+78.18%) 12:09 Today Fly Intel: Wall Street's top stories at midday 09:03 Today Fly Intel: Pre-market Movers 01/15/21 Fly Intel: Pre-market Movers 11/12/20 Fly Intel: Wall Street's top stories for Thursday 03/02/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/10/21 Five Prime - FPRX 08/16/21 PDUFA Date for Sotorasib AMGN FPRX AMGN Amgen $222.71 / -1.1 (-0.49%) 12/29/20 Early notable gainers among liquid option names on December 29th FPRX Five Prime $37.81 / +16.59 (+78.18%) 11/12/20 Unusually active option classes on open November 12th
Recommendations	Swiss Life price target lowered to CHF 492.90 from CHF 501.80 at Berenberg » 14:34 03/04/21 03/04 14:34 03/04/21 14:34 SZLMY Swiss Life $0.00 / + (+0.00%) Berenberg analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SZLMY Swiss Life $0.00 / + (+0.00%) 06:30 Today HSBC Swiss Life downgraded to Hold from Buy at HSBC 03/03/21 JPMorgan Swiss Life price target raised to CHF 460 from CHF 440 at JPMorgan 03/03/21 Credit Suisse Swiss Life price target raised to CHF 455 from CHF 365 at Credit Suisse 01/21/21 JPMorgan Swiss Life price target raised to CHF 440 from CHF 350 at JPMorgan
Recommendations	Shop Apotheke price target raised to EUR 235 from EUR 205 at Berenberg » 14:33 03/04/21 03/04 14:33 03/04/21 14:33 SAEYY Shop Apotheke $0.00 / + (+0.00%) Berenberg analyst Gerhard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SAEYY Shop Apotheke $0.00 / + (+0.00%) 01/21/21 Berenberg Shop Apotheke price target raised to EUR 205 from EUR 170 at Berenberg 01/12/21 Jefferies Shop Apotheke downgraded to Hold from Buy at Jefferies 01/12/21 Barclays Shop Apotheke price target raised to EUR 195 from EUR 190 at Barclays

Recommendations	Renishaw price target raised to 6,600 GBp from 6,200 GBp at Berenberg » 14:32 03/04/21 03/04 14:32 03/04/21 14:32 RNSHF Renishaw $0.00 / + (+0.00%) Berenberg analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RNSHF Renishaw $0.00 / + (+0.00%) 02/05/21 Berenberg Renishaw price target raised to 6,600 GBp from 6,200 GBp at Berenberg 02/05/21 Barclays Renishaw price target raised to 5,185 GBp from 4,350 GBp at Barclays 02/05/21 Morgan Stanley Renishaw price target raised to 5,100 GBp from 4,900 GBp at Morgan Stanley 10/30/20 Barclays Renishaw price target raised to 4,350 GBp from 2,940 GBp at Barclays
Recommendations	LafargeHolcim price target raised to CHF 52 from CHF 51 at Berenberg » 14:31 03/04/21 03/04 14:31 03/04/21 14:31 HCMLY LafargeHolcim $0.00 / + (+0.00%) Berenberg analyst Harry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals HCMLY LafargeHolcim $0.00 / + (+0.00%) 02/01/21 Cemex to divest certain assets in France to LafargeHolcim HCMLY LafargeHolcim $0.00 / + (+0.00%) 03/01/21 Credit Suisse LafargeHolcim price target raised to CHF 67 from CHF 64 at Credit Suisse 03/01/21 Morgan Stanley LafargeHolcim price target raised to CHF 64 from CHF 63 at Morgan Stanley 01/27/21 Exane BNP Paribas LafargeHolcim downgraded to Neutral from Outperform at Exane BNP Paribas 01/22/21 JPMorgan LafargeHolcim price target lowered to CHF 57 from CHF 59 at JPMorgan HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	Howden Joinery price target raised to 840 GBp from 830 GBp at Berenberg » 14:31 03/04/21 03/04 14:31 03/04/21 14:31 HWDJF Howden Joinery $0.00 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HWDJF Howden Joinery $0.00 / + (+0.00%) 02/26/21 JPMorgan Howden Joinery price target raised to 772 GBp from 679 GBp at JPMorgan 02/26/21 Canaccord Howden Joinery price target raised to 735 GBp from 710 GBp at Canaccord 01/29/21 Berenberg Howden Joinery upgraded to Buy from Hold at Berenberg 01/14/21 Canaccord Howden Joinery price target raised to 710 GBp from 675 GBp at Canaccord
Syndicate	Catalyst Biosciences files $150M mixed securities shelf 14:29 03/04/21 03/04 14:29 03/04/21 14:29 CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) 08:07 Today Catalyst Biosciences announces expected near-term milestones 02/03/21 Catalyst Biosciences presents SQ treatement of bleeds data 12/07/20 Catalyst Biosciences presents Crimson 1 Phase 3 study design 12/02/20 Catalyst Biosciences receives FDA fast track designation for MarzAA CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) 12:37 Today Piper Sandler Catalyst Biosciences' momentum to build throughout 2021, says Piper Sandler 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Piper Sandler Catalyst Biosciences initiated with an Overweight at Piper Sandler 02/09/21 JonesTrading Catalyst Biosciences assumed with a Buy at JonesTrading CBIO Catalyst Biosciences $5.91 / -0.36 (-5.74%) 08:05 Today Catalyst Biosciences reports Q4 EPS (86c), consensus (86c) 11/05/20 Catalyst Biosciences reports Q3 EPS (73c), consenus (81c) 27 Jan 18 Jun
Recommendations	Gecina price target lowered to EUR 135 from EUR 145 at Berenberg » 14:28 03/04/21 03/04 14:28 03/04/21 14:28 GECFF Gecina $0.00 / + (+0.00%) Berenberg lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GECFF Gecina $0.00 / + (+0.00%) 03/02/21 Barclays Gecina price target lowered to EUR 127 from EUR 132 at Barclays 02/22/21 Morgan Stanley Gecina price target lowered to EUR 120 from EUR 130 at Morgan Stanley 02/19/21 JPMorgan Gecina downgraded to Neutral from Overweight at JPMorgan 02/19/21 Deutsche Bank Gecina price target lowered to EUR 137 from EUR 142 at Deutsche Bank

Recommendations	Croda price target raised to 7,400 GBp from 7,200 GBp at Berenberg » 14:27 03/04/21 03/04 14:27 03/04/21 14:27 COIHY Croda International $0.00 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research COIHY Croda International $0.00 / + (+0.00%) 03/03/21 Barclays Croda International price target raised to 6,000 GBp from 5,650 GBp at Barclays 01/25/21 Morgan Stanley Croda price target raised to 6,800 GBp from 6,500 GBp at Morgan Stanley 12/10/20 Berenberg Croda International upgraded to Buy from Hold at Berenberg 12/07/20 Morgan Stanley Croda price target lowered to 6,500 GBp from 6,600 GBp at Morgan Stanley
Options	Teck Resources call volume above normal and directionally bullish » 14:25 03/04/21 03/04 14:25 03/04/21 14:25 TECK Teck Resources $20.44 / -1.17 (-5.41%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options TECK Teck Resources $20.44 / -1.17 (-5.41%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/16/21 Teck Resources doubles water treatment capacity at Elkview operations 01/07/21 Teck Resources, Ktunaxa Nation sign joint management agreement 11/27/20 Teck Resources expands Copper and Health program to Chile TECK Teck Resources $20.44 / -1.17 (-5.41%) 03/01/21 CIBC Teck Resources price target raised to C$32 from C$25 at CIBC 02/19/21 TD Securities Teck Resources price target raised to C$34 from C$30 at TD Securities 02/19/21 RBC Capital Teck Resources price target lowered to C$32 from C$33 at RBC Capital 02/19/21 B. Riley Securities Teck Resources price target raised to C$33 from C$31 at B. Riley Securities TECK Teck Resources $20.44 / -1.17 (-5.41%) 02/18/21 Teck Resources reports Q4 adjusted EPS C$0.46 vs, C$0.40 last year 10/27/20 Teck Resources reports Q3 adj. EPS C$0.24 vs. C$0.69 last year 04/28/21 Teck Resources - TECK TECK Teck Resources $20.44 / -1.17 (-5.41%) 03/03/21 Teck Resources call volume above normal and directionally bullish 02/23/21 Teck Resources put volume heavy and directionally bearish 02/19/21 Teck Resources call volume above normal and directionally bullish 02/12/21 Teck Resources put volume heavy and directionally bearish
Syndicate	Ball Corp. files automatic mixed securities shelf 14:23 03/04/21 03/04 14:23 03/04/21 14:23 BLL Ball Corp. $82.48 / -2.11 (-2.49%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events BLL Ball Corp. $82.48 / -2.11 (-2.49%) 02/10/21 Ball Aerospace selected to integrate, test Sailcraft for NASA 02/09/21 Ball Aerospace to build spacecraft for NASA heliophysics science mission 02/04/21 Ball sees FY21 EPS over growth goal of 10%-15% 01/26/21 Ball Corp.to begin construction on production facility in West of Czech Republic BLL Ball Corp. $82.48 / -2.11 (-2.49%) 01/20/21 Deutsche Bank Ball Corp. price target lowered to $102 from $107 at Deutsche Bank 01/04/21 Baird Baird sees limited upside for Ball Corp, downgrades shares to Neutral 01/04/21 Baird Ball Corp. downgraded to Neutral from Outperform at Baird 11/10/20 Wells Fargo Ball Corp. price target raised to $100 from $80 at Wells Fargo BLL Ball Corp. $82.48 / -2.11 (-2.49%) 02/04/21 Ball reports Q4 EPS 68c, consensus 78c 11/05/20 Ball Corp. reports Q3 comparable EPS 89c, consensus 77c 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open BLL Ball Corp. $82.48 / -2.11 (-2.49%) 12/14/20 Ball Corp. added as short trade best idea at Hedgeye, Bloomberg says 03/03/21 2021 Global Agriculture & Materials Virtual Conference
Technical Analysis	NASDAQ market internals summary » 14:17 03/04/21 03/04 14:17 03/04/21 14:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 14:16 03/04/21 03/04 14:16 03/04/21 14:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary

Events

Earnings calls, analyst events, roadshows and more

MTSI
Today at 15:00

MACOM Technology Solutions Holdings, Inc. Firm Sponsored Meetings

the Holiday Inn Express, 8 Independence Drive, Chelmsford, MA
Today at 16:30

Fed Balance Sheet Reserve Bank Credit W/W: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Level: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Total Assets W/W: Week 3/3/21 Government Event
ATEC
Today at 16:30

Alphatec - ATEC Conference Calls
ACOR
Today at 16:30

Acorda Therapeutics - ACOR Conference Calls
CLPT
Today at 16:30

ClearPoint Neuro - CLPT Conference Calls
FLGT
Today at 16:30

Fulgent Genetics - FLGT Conference Calls
SIGA
Today at 16:30

Siga Technologies - SIGA Conference Calls
SYN
Today at 16:30

Synthetic Biologics - SYN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital $149.49 7M Shares
Fri	No deals

View All Syndicate Announcements »

EZGO Technologies 2.8M share IPO priced at $4.00

TODAY'S FREE FLY STORIES

Get Full Fly Access